Trump-Politik drückt Pharmatitel – Lohnt sich der Einstieg? / Zollstreit macht Boschs neues US-Chipwerk zum Supercoup
Die Pharma-Branche kämpft mit Preisdruck und Patentverlusten, doch neue Chancen locken Anleger. Und: Bosch könnte mit seinem US-Chipwerk zum Profiteur der Handelskonflikte werden.
You May Also Like
The Real Estate Espresso Podcast
Victor Menasce
Datasets
Visionary
Index
Podcasty SME
손에 잡히는 경제
MBC
硬核比特--人工智能硬核比特币新闻
Meng
Million Dollar Electrician - Sale to Scale For Home Service Pros
Clay Neumeyer
How Money Works
How Money Works
Bloomberg Talks
Bloomberg
Marketplace All-in-One
Marketplace
Marketplace
Marketplace
The Real Estate Espresso Podcast
Victor Menasce
Datasets
Visionary
Index
Podcasty SME
손에 잡히는 경제
MBC
硬核比特--人工智能硬核比特币新闻
Meng
Million Dollar Electrician - Sale to Scale For Home Service Pros
Clay Neumeyer
How Money Works
How Money Works
Bloomberg Talks
Bloomberg
Marketplace All-in-One
Marketplace
Marketplace
Marketplace
Community discussion